Completed | June 2022

Evaluating the Effectiveness of the Pratt Pouch on Completion of Six Weeks of Nevirapine Prophylaxis

Overview

Country:

Uganda

Subject Matter:

Innovative Technologies; PMTCT and HIV-free Survival

This Saving Lives at Birth study evaluated the effectiveness of the innovative Pratt Pouch as a tool for expanding access to infant Nevirapine prophylaxis for HIV-exposed infants in Uganda. The mixed methods study included a pre- and post-intervention survey of mothers as well as the collection of costing data to inform policy.

Data Collection Period: 09/2019 – 01/2020

Publications and Presentations:

  1. Findings presented at the 12th International Workshop on HIV & Pediatrics, November 2020: “Effects of Pratt Pouch on HIV-Exposed Infants in Completing Full Six-Week Nevirapine Prophylaxis Regimen in Uganda“
  2. Findings published in PLOS ONE, March 2021: “Effects of the Pratt pouch model of dispensing nevirapine prophylaxis on HIV exposed infant completion of 6 weeks of prophylaxis in Uganda“

Explore Other Research

In Analysis Birth Surveillance in Eswatini Following Transition To Dolutegravir-based Treatment Maternal, Newborn, and Child Health; PMTCT and HIV-free Survival
Ongoing Data Collection Pediatric HIV community case finding and assessment of PMTCT effectiveness in Lesotho PMTCT and HIV-free Survival
Completed Uptake, Feasibility and User Acceptability of VISITECT CD4 Point of Care Test among Healthcare Workers in Tanzania Adult Testing, Care, and Treatment; Innovative Technologies
All Research